+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Bronchopulmonary Dysplasia - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bronchiectasis - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchiectasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 70 Pages
  • Global
From
Bacterial Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Leukotriene D4 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Leukotriene D4 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leukotriene Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Leukotriene Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Lung Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Lung Injury - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Refractory Cough - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Refractory Cough - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Obstructive Sleep Apnea (OSA) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Obstructive Sleep Apnea (OSA) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 75 Pages
  • Global
From
From
From
TRELEGY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

TRELEGY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
CINQAIR Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

CINQAIR Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
SPIRIVA RESPIMAT Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

SPIRIVA RESPIMAT Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
FASENRA Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

FASENRA Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
NUCALA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

NUCALA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
XOLAIR Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

XOLAIR Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more